However, due to the lack of integrated analysis of epigenomic and transcriptome data, the specific role of DNA methylation sites and TNF-related gene expression changes in GBM progress, as well as potential effective drugs associated with these genes, are still unclear. The gene discussed is TNF; the disease is glioblastoma.